BRIELLYN TABLET

BRIELLYN TABLET is a generic prescription medication. It is tracked in the NADAC database with a current average price of $0.4341 per each (tablet/capsule).

Based on NADAC (National Average Drug Acquisition Cost) data, BRIELLYN TABLET has an average price of $0.4341 per each (tablet/capsule). Prices range from $0.4341 to $0.4341. Actual retail prices may vary by pharmacy and location.

Yes, BRIELLYN TABLET is classified as a generic medication. Generic drugs are required by the FDA to have the same active ingredients, strength, and dosage form as their brand-name counterparts, but are typically available at significantly lower prices.

Yes, Briellyn (Norethindrone-Ethin. Estradiol) is included in Medicare Part D spending data. In 2023, total Medicare spending on this drug was $24.0K. Medicare Part D plans may cover this medication, but coverage varies by plan. Check with your specific Part D plan for details.

All pricing data comes from the NADAC (National Average Drug Acquisition Cost) database published by the Centers for Medicare & Medicaid Services (CMS). Medicare spending data comes from the Medicare Part D Spending by Drug dataset. FDA drug details come from the National Drug Code Directory. All sources are official U.S. government data.

To reduce costs on BRIELLYN TABLET: Compare prices at different pharmacies. Check if your insurance or Medicare plan covers it. Look into patient assistance programs from the manufacturer. Consider mail-order pharmacies for maintenance medications. GoodRx and similar services may offer additional discounts.